Pricing Log in Create free account

Bio-Path Holdings, Inc. (BPTH) vs Altamira Therapeutics Ltd. (CYTOF)

Bio-Path Holdings, Inc. and Altamira Therapeutics Ltd. are both Biotechnology companies. Bio-Path Holdings, Inc. and Altamira Therapeutics Ltd. are of similar size ($1.1M and $1.1M). Across the 8 metrics below, Bio-Path Holdings, Inc. leads on 5 and Altamira Therapeutics Ltd. on 3.

Valuation

Metric BPTH CYTOF Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B n/m n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.00 n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield 0.00% (44,544.44%) (33.15%)
Free cash flow yield 0.00% (9,080,722.22%) (25.50%)

Profitability

Metric BPTH CYTOF Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 157.01% 0.00% (56.36%)
Return on assets (605.50%) 0.00% (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BPTH CYTOF Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 87.75% 81.52% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BPTH CYTOF Biotechnology median
Debt to equity 0.00 0.11 0.00
Current ratio 0.07 0.11 4.72
Net debt to EBITDA 0.10 (0.27) 0.96

Dividend

Metric BPTH CYTOF Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric BPTH CYTOF Biotechnology median
Market cap 1.07m 1.13m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack